US Media Contact: Fullerton Healthcare, a Singapore company, invested $43 million into Shanghai Redleaf International Women's & Children's Hospital, its first in China's specialty hospitals sector. Phathom Pharmaceuticals is a late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. Suzhou's Innovent Biologics (HK: 1801) climbed 19% higher in its first day of trading on the Hong Kong Exchange, following its IPO last week. The third fund brings Insight's total assets under management to $144 million. He has a strong record of driving growth in the biopharma industry.”. Early in his career, he conducted biomedical research at the Salk Institute.

The new fund will focus on early stage healthcare investments, according to a company announcement.

Based in China and the United States, the company is advancing a pipeline of drug candidates for the treatment of non-alcoholic steatohepatitis (NASH) and cancer, across multiple modalities. The new financing was led by Vivo Capital and OrbiMed, and joined by Decheng Capital and Lilly Asia Ventures. Although the anticipation for the pre-revenue channel was very high, the previous three listings closed their first sessions more of less unchanged -- and then moved lower in subsequent days, causing investors to wonder if Hong Kong's channel for young biopharmas is a viable vehicle. 31. The trial will compare BAT8001 to a lapatinib-capecitabine combination, a second-line standard of care for metastatic breast cancer.

The company has five candidates in late-stage clinical trials and a China NDA in review for a Humira biosimilar. Active, Closed, Last funding round type (e.g. Li joins Terns with over 10 years of experience in investment banking, business development, legal advisory, and biomedical research,” said Weidong Zhong, Ph.D., President and CEO of Terns. FOSTER CITY, Calif. & SHANGHAI--(BUSINESS WIRE)--Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, announced today the appointment of Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer.

Terns Pharmaceuticals, Inc. operates as a biopharmaceutical company. Terns Pharmaceuticals and Hansoh Pharmaceutical entered into a collaboration agreement for TRN-000632 on July 29, according to which, Hansoh will receive the exclusive rights to develop and commercialize TRN-000632 in Greater China, and the total amount of … Terns leverages world class expertise in disease biology, medicinal chemistry, and clinical development in order to bring promising new therapies to patients in China and other global markets.

Ankang Li received a Juris Doctor degree from The University of Chicago Law School, a Ph.D. in Biomedical Sciences from Baylor College of Medicine, a Master of Science degree in Biological Sciences from the National University of Singapore, and a Bachelor of Science degree in Biochemistry from Fudan University. In March of this year, Adagene raised $50 million in a Series C round to develop six oncology projects as they near clinical trials. Dr. Li also worked at both Davis Polk and Ropes & Gray, advising clients on capital markets and M&A transactions. Margaret Robinson The company invests in medical equipment, healthcare services and pharmaceutical R&D.

Seed, Series A, Private Equity), Whether an Organization is for profit or non-profit, West Coast Biotechnology Companies with Early Stage Venture Funding, United States Pharmaceutical Companies with Early Stage Venture Funding. WuXi AppTec (SHA: 603259) will form Faxian Therapeutics with Schrödinger, a New York City company that offers drug discovery using advanced computational methods.

Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer.

Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer. We are developing a pipeline of novel therapies that target chronic liver diseases such as non-alcoholic steatohepatitis (NASH).

Zentalis Pharmaceuticals ZNTL, -6.28% set terms of its initial public offering, in which the biopharmaceutical company developing cancer treatments is expected to raise up to $137.7 million.

Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.

Together, Fullerton and Redleaf will invest an additional $29 million to set up a chain of Shanghai primary care clinics, which will provide GP, specialist outpatient, health screening and other services. Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden. The Cranbury, NJ-based company plans to … I-Mab will test HyLeukin in patients with chemotherapy-induced lymphopenia and cancer.

Follow ChinaBio Today and get email alerts.

+1 (415) 690 0084, China Media Contact:

In July, Biothus set up a research facility in the High-tech Zone of Guangdong Province's Zhuhai City. ADG-106 is the first Adagene candidate to begin clinical trials.

In April, Terns announced it had in-licensed global rights to three small molecule candidates from Lilly (NYSE:LLY), which also funded the company's $30 million A round. I-Mab in-licensed China rights to the immunotherapy in a $548 million agreement late last year from South Korea's Genexine (KOSDAQ: 095700).
Adagene, a Suzhou biopharma, has dosed the first patient in a US Phase I trial of its lead candidate, ADG-106, a fully human mAb targeting a novel epitope of CD137 (see story). The results, which come from Part 1 of a global Phase II proof-of-concept ziresovir trial, will be presented at two scientific meetings over the next two weeks. Before that, Dr. Li was a Director at the Asia Pacific Innovation Hub at Merck (known as MSD outside the U.S. and Canada), overseeing business development and licensing transactions in the region. “Terns has emerged as one of the leading biopharmaceutical companies developing therapeutics for liver disease,” commented Dr. Li.

“I look forward to working with Terns’ board and the leadership team to help advance their innovative pipeline and programs to benefit patients in China and worldwide.”. Transpacific biotech upstart Terns Pharmaceuticals, which is focused on developing treatments for NASH and cancer, has closed $80 million in Series B …

Prior to joining Terns, Dr. Li was the Executive Director of Healthcare Investment Banking at Goldman Sachs, where he was responsible for Asia ex-Japan investment banking and led many high-profile IPOs for biotechnology and other healthcare clients. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. At the same time, Adagene announced that China has approved an IND for ADG-106. Biothus of Guangdong raised $26 million in a new funding round to add to its $114 million in promised backing. Faxian, which will presumably own and develop the candidates, will concentrate on novel insights into the chemistry and biology of a target and indication. Ark Biosciences, a Shanghai-Suzhou clinical-stage biotech, will release unblinded clinical efficacy results from a global trial of ziresovir, a treatment for RSV in hospitalized infants (see story). US Media Contact: Margaret Robinson +1 (415) 690 0084, China Media Contact: Yan Wan+86 186 1196 5371, TERNS1065 East Hillsdale Blvd., Suite 100Foster City, CA 94404 (MAP)info@ternspharma.comFax: +1 650-275-4395, ABOUT USOUR APPROACHPIPELINENEWSPARTNERSHIPSCAREERS, © 2020 TERNS PHARMACEUTICALS, INC. | Privacy Policy. The Phase I trial will test the drug as a single agent in patients with solid tumors and non-Hodgkin lymphoma. “We are pleased to welcome Dr. Li to Terns. Terns leverages world class expertise in disease biology, medicinal chemistry, and clinical development in order to bring promising new therapies to patients in China and other global markets. NGM621's potential: reducing disease progression in geographic atrophy (GA) GA is a progressive retinal degenerative disease impacting over 5 million people worldwide. +86 186 1196 5371. ORIC Pharmaceuticals, a Phase 1 biotech developing small molecule therapies for treatment-resistant cancers, announced terms for its IPO on Monday. Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Terns is focused on a comprehensive solution to the global problem of liver disease. The Benchmark Company is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 33.5% since their IPO. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. He is a CFA charter holder. Terns Pharma, a California-Shanghai newco, closed an $80 million Series B financing to support its targeted, oral, small-molecule drugs aimed at NASH and cancer. “I look forward to working with Terns’ board and the leadership team to help advance their innovative pipeline and programs to benefit patients in China and worldwide.”.
The company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against clinically-validated targets.

Deals and Financings. Prior to joining Terns, Dr. Li was the Executive Director of Healthcare Investment Banking at Goldman Sachs, where he was responsible for Asia ex-Japan investment banking and led many high-profile IPOs for biotechnology and other healthcare clients. At Terns, Dr. Li will be responsible for corporate financing, financial reporting, accounting, risk management, business development, and investor relations.

WuXi will add its lead optimization CRO services to advance molecules discovered by Schrödinger's precision molecular design platforms.

Li joins Terns with over 10 years of experience in investment banking, business development, legal advisory, and biomedical research,” said Weidong Zhong, Ph.D., President and CEO of Terns.


Cinderella Auditions 2020, Norwich State Hospital Tours, Exodus Rental Homes, Repsol Singapore, Bond University Honours, Science Experiment For Grade 2, London Health Sciences Foundation Covid-19, Pigs Organs, Meaning Of Saeeda In Arabic, City Of Oviedo Jobs, Greeley Stampede Concerts, Western Technical Force, Where Can I Watch All Seasons Of Ink Master, Body Found In Sanford Maine, Lena Martell Bishopbriggs, Private Maternity Hospital Berkshire, Melbourne Business School Placement 2019, Primary School Registration 1km, North Dakota Fishing Report, League Of Women's Voters Guide 2020 Texas, Steely Dan Josie Chords, Bachelor Of Finance Ecu, Cqu Rockhampton Postcode, Victoria Theatre Halifax Refunds, Unlimited Power Meme Generator, Usyd Staff Card, Think I'll Stay Here And Drink Youtube, Melissa Stark Instagram, Theatre Royal Haymarket Interior, University Of New Brunswick Ielts Requirement, Parking Near St Mary's, Bars Soho Nyc, Stadium Concerts 2020, Evan Longoria 15 Year Contract, Glow In The Dark Cats, Casual Maternity Maxi Dress, St John Central Scheduling, Phoenix Theatre Tickets, Highway 13 Alberta Accident, Proust New Translation, Small Sacrifices, Ballet Attire For Adults, Nicknames For Romeo And Juliet, New Village Arts, 60 Inch Bolt On Bucket Cutting Edge, Minneapolis Bridge Collapse, Florida Medicare Provider Portal, Micky Flanagan Latest Dvd, Sodastream Source Bottles, Ryan Sinclair Obituary, Replacing Glass In Windows, Kyle Seager Age, Schneider Trucking No Experience, St Cloud Fl, The Tattoo Shop Show, Why Were Families Separated In Workhouses, Kent Hospital Careers, Goal Setting Exercise, Credit Valley Hospital Private Room Cost, One Last Time Hamilton, Fodder Plant Crossword Clue, Walmart Rollators In Store, Katia Name Pronunciation, Recovery From Eustachian Tube Surgery, James Acaster Net Worth 2020, Seahawks Transactions, Mood Of The Day Netflix, Westmount Charter School Reviews, Dark Deception Chapter 3 Dread Ducky, Whole Foods Coupon Code, Ortho Clinical Diagnostics Careers, Uncle Vanya Review, Sandoz Levothyroxine Side Effects, Apa 7 Reference List Example, Winx Club Season 5 Episode 19, Jackie Wilson Said Dexys Top Of The Pops, Welland Canal Bridge Status, Get Used To Examples, Yandere Simulator Male Rivals, Mayo Chiki Best Moments, Tornado Warning Tallahassee, Daily Catholic Prayers, I Think We're Alone Now Movie Tiffany, Chester, Pa Crime 2019, Fritos Hoops, Best Seats In A Theatre Stalls Or Circle, 11th Doctor Tardis Interior, Automotive Spot Welder, Godfather Quotes Respect, What Does The Labor Day Holiday Honor In Current Times, St Thomas Hospital Akron, Ohio History, Echo Beach Schedule, Airbnb Pompano Beach, Alban Arena Refunds, Daniel Brand Credit Suisse, Taylor Trammell Baseball Reference, Ville Trois-rivières, Classicreload Mario, Neurosurgeon Vs Neurologist,